Literature DB >> 26573668

[Improved prostate cancer treatment in certified centers : Is the strategic vision realistic?].

J Steffens1, J Kranz2, P Albers3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26573668     DOI： 10.1007/s00120-015-3835-y

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  5 in total

1.  In Reply.

Authors:  Barbara Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2015-10-30       Impact factor: 5.594

2.  Results of radical prostatectomy in newly diagnosed prostate cancer: long-term survival rates in locally advanced and high-risk cancers.

Authors:  Hendrik Isbarn; Hartwig Huland; Markus Graefen
Journal:  Dtsch Arztebl Int       Date:  2013-07-22       Impact factor: 5.594

3.  A single center prospective study: prediction of postoperative general quality of life, potency and continence after radical retropubic prostatectomy.

Authors:  Adrian Treiyer; Petra Anheuser; Zentia Bütow; Joachim Steffens
Journal:  J Urol       Date:  2011-03-21       Impact factor: 7.450

Review 4.  Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.

Authors:  Riccardo Valdagni; Hendrik Van Poppel; Michael Aitchison; Peter Albers; Dominik Berthold; Alberto Bossi; Maurizio Brausi; Louis Denis; Lawrence Drudge-Coates; Maria De Santis; Günther Feick; Chris Harrison; Karin Haustermans; Donal Hollywood; Morton Hoyer; Henk Hummel; Malcolm Mason; Vincenzo Mirone; Stefan C Müller; Chris Parker; Mahasti Saghatchian; Cora N Sternberg; Bertrand Tombal; Erik van Muilekom; Maggie Watson; Simone Wesselmann; Thomas Wiegel; Tiziana Magnani; Alberto Costa
Journal:  Crit Rev Oncol Hematol       Date:  2015-06-05       Impact factor: 6.312

Review 5.  [Radical prostatectomy in a certified prostate cancer center: medical treatment and outcome].

Authors:  J Kranz; O Deserno; K Fischer; P Anheuser; B Reisch; J Steffens
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.